InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: marzan post# 229011

Wednesday, 11/20/2019 7:58:18 PM

Wednesday, November 20, 2019 7:58:18 PM

Post# of 425848

BS. Plus Mochida has a NASH patent and Amarin has a partnership with Mochida. Plus plus RIt trial has NASH data yet to be published that says while Amarin is intending to file for a NASH indication, how could thjey let GILD take it not even for a song? Ridiculous!



Gilead is not taking anything. Just like Amarin didn't take statins away from their manufacturers in the REDUCE-IT trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News